A review of immunotherapy for stage 3 and metastatic
NSCLC
& the rationale for the
ECOG‐ACRIN EA5181
study
John M Varlotto
◽
Zhuoxin Sun
◽
Bonnie Ky
◽
Jenica Upshaw
◽
Sharyn I Katz
◽
...
2020 ◽
Vol 31
◽
pp. S838
◽
K. Nakagawa
◽
E. Nadal
◽
E.B. Garon
◽
M. Nishio
◽
T. Seto
◽
...
2021 ◽
Vol 16
(3)
◽
pp. S219
E. Lenci
◽
L. Cantini
◽
S. Rinaldi
◽
F. Pecci
◽
V. Cognigni
◽
...
Erika Rijavec
◽
Alice Indini
◽
Michele Ghidini
◽
Gianluca Tomasello
◽
Monica Cattaneo
◽
...
David M Waterhouse
◽
Wan-Yu Tseng
◽
Janet L Espirito
◽
Nicholas J. Robert